WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
What you need to know after a breast cancer diagnosis

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr
OB & GYN October 24,2024
What you need to know after a breast cancer diagnosis

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr
OB & GYN October 24,2024
The Tragic Loss of Dr. Jane Y. Wu: A Brilliant Neuroscientist's Untimely Demise

The Tragic Loss of Dr. Jane Y. Wu: A Brilliant Neuroscientist's Untimely Demise

The scientific community was left reeling from the shocking news of Dr. Jane Y. Wu's death on July 10, 2024. A prominent neuroscientist and respected researcher at Northwestern University, Dr. Wu's passing at the age of 60 has sparked discussions about th
Neurology October 24,2024
The Tragic Loss of Dr. Jane Y. Wu: A Brilliant Neuroscientist's Untimely Demise

The Tragic Loss of Dr. Jane Y. Wu: A Brilliant Neuroscientist's Untimely Demise

The scientific community was left reeling from the shocking news of Dr. Jane Y. Wu's death on July 10, 2024. A prominent neuroscientist and respected researcher at Northwestern University, Dr. Wu's passing at the age of 60 has sparked discussions about th
Neurology October 24,2024
Huawei AI Transforms Communication for People with Speech Disabilities!

Huawei AI Transforms Communication for People with Speech Disabilities!

“Humanity became what it is because we learned to care for our sick.”On October 22, 2024, Huawei held a press conference in Shenzhen, China, where it not only launched a new smartphone but also officially announced the complete independence of the Harmony
ENT & HN October 23,2024
Huawei AI Transforms Communication for People with Speech Disabilities!

Huawei AI Transforms Communication for People with Speech Disabilities!

“Humanity became what it is because we learned to care for our sick.”On October 22, 2024, Huawei held a press conference in Shenzhen, China, where it not only launched a new smartphone but also officially announced the complete independence of the Harmony
ENT & HN October 23,2024
Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi
Oncology October 22,2024
Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi
Oncology October 22,2024
Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe
Oncology October 22,2024
Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe
Oncology October 22,2024
Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc
Oncology October 22,2024
Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc
Oncology October 22,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com